Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$712M |
| 2 |
PepsiCo
PEP
|
+$669M |
| 3 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$635M |
| 4 |
Walmart Inc
WMT
|
+$544M |
| 5 |
Palantir
PLTR
|
+$538M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.34B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.65B |
| 3 |
Tesla
TSLA
|
+$1.45B |
| 4 |
Invesco QQQ Trust
QQQ
|
+$1.01B |
| 5 |
Apple
AAPL
|
+$833M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.48% |
| 2 | Financials | 7.27% |
| 3 | Consumer Discretionary | 6.82% |
| 4 | Communication Services | 5.06% |
| 5 | Healthcare | 4.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2001
CALL
First Solar
FSLR
$26.2B
| $6.33M | ﹤0.01% |
28,700
-184,400
| -87% | -$35.4M |
|
2002
Vera Therapeutics
VERA
$2.15B
| $6.32M | ﹤0.01% |
217,593
+6,716
| +3% | +$155K |
|
2003
Marqeta
MQ
$1.89B
| $6.32M | ﹤0.01% |
299,314
-35,933
| -11% | -$851K |
|
2004
CALL
Biohaven
BHVN
$2.07B
| $6.32M | ﹤0.01% |
+420,900
| New | +$6.13M |
|
2005
GitLab
GTLB
$6.16B
| $6.32M | ﹤0.01% |
140,118
-69,587
| -33% | -$3.18M |
|
2006
CALL
Darling Ingredients
DAR
$9.56B
| $6.31M | ﹤0.01% |
204,500
+129,500
| +173% | +$4.33M |
|
2007
CALL
SLB Ltd
SLB
$75.4B
| $6.28M | ﹤0.01% |
182,800
-31,500
| -15% | -$1.1M |
|
2008
CALL
Ivanhoe Electric
IE
$1.66B
| $6.28M | ﹤0.01% |
+500,000
| New | +$4.94M |
|
2009
CALL
Capital One
COF
$136B
| $6.27M | ﹤0.01% |
29,500
-182,900
| -86% | -$40M |
|
|
PONY
2010
Pony AI Inc
PONY
$3.49B
| $6.27M | ﹤0.01% |
278,714
-2,496
| -0.9% | -$38K |
|
2011
First American
FAF
$7.76B
| $6.25M | ﹤0.01% |
97,246
+43,706
| +82% | +$2.76M |
|
2012
NeoGenomics
NEO
$2.09B
| $6.22M | ﹤0.01% |
805,555
+541,677
| +205% | +$3.79M |
|
2013
PUT
CSX Corp
CSX
$94.5B
| $6.21M | ﹤0.01% |
175,000
-170,000
| -49% | -$5.81M |
|
2014
CG Oncology
CGON
$6.3B
| $6.2M | ﹤0.01% |
153,955
-192,545
| -56% | -$5.6M |
|
2015
Avnet
AVT
$7.59B
| $6.18M | ﹤0.01% |
118,305
+66,230
| +127% | +$3.56M |
|
2016
Graphic Packaging
GPK
$3.52B
| $6.17M | ﹤0.01% |
315,505
-1,799
| -0.6% | -$39.1K |
|
2017
Andersons Inc
ANDE
$2.54B
| $6.17M | ﹤0.01% |
154,906
+9,907
| +7% | +$382K |
|
2018
Dorman Products
DORM
$4.42B
| $6.17M | ﹤0.01% |
39,560
-16,811
| -30% | -$2.41M |
|
2019
Kemper
KMPR
$1.73B
| $6.16M | ﹤0.01% |
119,563
-277,002
| -70% | -$15.6M |
|
2020
Academy Sports + Outdoors
ASO
$3.02B
| $6.15M | ﹤0.01% |
122,963
-4,739
| -4% | -$242K |
|
2021
PUT
Royal Caribbean
RCL
$87.1B
| $6.15M | ﹤0.01% |
19,000
-236,000
| -93% | -$78.8M |
|
2022
Triple Flag Precious Metals
TFPM
$6.18B
| $6.15M | ﹤0.01% |
210,068
-12,134
| -5% | -$314K |
|
2023
Arcutis Biotherapeutics
ARQT
$3.26B
| $6.14M | ﹤0.01% |
325,968
-68,073
| -17% | -$1.07M |
|
|
TPC
2024
Tutor Perini Cor
TPC
$4.51B
| $6.14M | ﹤0.01% |
93,676
-17,857
| -16% | -$995K |
|
2025
AMN Healthcare
AMN
$1.29B
| $6.14M | ﹤0.01% |
317,234
-324,096
| -51% | -$6.33M |
|
Similar funds
Barclays's Q3 2025 Portfolio in Review
As of Q3 2025, Barclays held 5,800 positions worth $461B, up 5.7% from $436B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Barclays's Q3 2025 filing shows 615 new, 1,596 increased, 2,751 reduced and 340 closed positions. Its largest new stake was Paramount Skydance Corp: 13,646,704 shares worth $258M. The largest sale was NVIDIA, an estimated $2.34B.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
- Barclays's largest Q3 2025 buy was Paramount Skydance Corp: 13,646,704 shares worth $258M.
- Barclays added most to iShares iBoxx $ High Yield Corporate Bond ETF in Q3 2025, an estimated $712M increase.
- Barclays's biggest Q3 2025 reduction was NVIDIA, cutting an estimated $2.34B.
- Barclays fully exited Blueprint Medicines in Q3 2025, selling an estimated $200M.
- Barclays's ten largest holdings make up 40% of its $461B portfolio in Q3 2025.
- Barclays opened 615 new positions and closed 340 in Q3 2025.
- Barclays's portfolio value rose 5.7% quarter-over-quarter to $461B.
Based on Barclays's 13F filing for Q3 2025, filed 12 Nov 2025.